CooperCompanies (NASDAQ:COO) Misses Q4 Revenue Estimates, Stock Drops 11%
Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.6% year on year to $964.7 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.12 billion at the midpoint. Its non-GAAP profit of $0.92 per share was in line with analysts’ consensus estimates.